Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-221339
Filing Date
2022-08-15
Accepted
2022-08-15 17:48:26
Documents
49
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d360354d10q.htm   iXBRL 10-Q 704213
2 EX-31.1 d360354dex311.htm EX-31.1 11165
3 EX-31.2 d360354dex312.htm EX-31.2 11156
4 EX-31.3 d360354dex313.htm EX-31.3 11088
5 EX-32.1 d360354dex321.htm EX-32.1 4703
6 EX-32.2 d360354dex322.htm EX-32.2 4671
7 EX-32.3 d360354dex323.htm EX-32.3 4540
  Complete submission text file 0001193125-22-221339.txt   3732508

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ignyu-20220630.xsd EX-101.SCH 33309
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ignyu-20220630_cal.xml EX-101.CAL 18246
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ignyu-20220630_def.xml EX-101.DEF 123204
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ignyu-20220630_lab.xml EX-101.LAB 241670
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ignyu-20220630_pre.xml EX-101.PRE 192783
43 EXTRACTED XBRL INSTANCE DOCUMENT d360354d10q_htm.xml XML 597930
Mailing Address 277 PARK AVENUE, 26TH FLOOR NEW YORK NY 10172
Business Address 277 PARK AVENUE, 26TH FLOOR NEW YORK NY 10172 (212) 818-8800
Ignyte Acquisition Corp. (Filer) CIK: 0001834645 (see all company filings)

EIN.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39951 | Film No.: 221167154
SIC: 2836 Biological Products, (No Diagnostic Substances)